Research paper
Chronic subcutaneous infusion of neurosecretory protein GM increases body mass gain in chicks

https://doi.org/10.1016/j.ygcen.2017.11.010Get rights and content

Highlights

  • The biological action of neurosecretory protein GM (NPGM) was surveyed in chicks.

  • Chronic subcutaneous infusion of NPGM increased body mass gain.

  • This effect seems to be due to increased mass of white adipose tissue.

Abstract

Recently we discovered a small hypothalamic protein in the chicken, named neurosecretory protein GL (NPGL), which is associated with body growth and energy metabolism in birds and rodents. Genome database analysis suggested that the NPGL gene has a paralogous gene in vertebrates, named neurosecretory protein GM (NPGM). However, the biological action of NPGM remains unclear. In this study, we investigated whether NPGM affects body growth in chicks. We found that subcutaneous infusion of NPGM for six days increased body mass gain in a dose-dependent manner. Despite the observed increase in body mass, infusion of NPGM did not alter food and water intake. Of note, we observed tendency of mass increase of several peripheral tissues, specifically. When we compared several tissue types, NPGM seemed to induce the largest growth increase in white adipose tissue mass. These results suggest that NPGM may accelerate fat accumulation and body growth. In addition, we analyzed whether NPGM increases body growth through the action of pituitary hormones. However, we observed no significant changes in mRNA expression of pituitary hormones or plasma levels of growth hormone in NPGM-treated chicks. This is the first report describing the biological action of NPGM in vertebrates.

Introduction

Body growth in animals is regulated by various hormones and genetic, nutritional, and environmental factors (Harvey, 2013). In particular, growth hormone (GH) is generally regarded as essential for body growth and development in vertebrates. GH excess results in gigantism, whereas GH deficiency results in dwarfism (Gahete et al., 2016, Hannah-Shmouni et al., 2016. Several neuropeptides, including growth hormone-releasing hormone (GHRH), ghrelin, and somatostatin (Burgus et al., 1973, Guillemin et al., 1982, Kojima et al., 1999), regulate production and secretion of GH. Growth in peripheral tissues, including liver, muscle, and adipose tissue, is mainly regulated by GH and insulin-like growth factors (IGFs) working with their respective receptors (Harvey, 2013, Hyun, 2013). However, as these tissues are associated with energy metabolism, increases in their masses are also influenced by energy state. Furthermore, various other bioactive substances can also influence body mass growth, such as neuropeptide Y (NPY), glucocorticoids, and leptin, which regulate feeding behavior and bone metabolism (Baldock et al., 2006, Engblom et al., 2007, Takeda et al., 2002). These neuropeptides, peripheral steroids, or peptide hormones are secreted from the hypothalamus, adrenal gland, and adipose tissue in response to physiological conditions. In this way, body growth is regulated by various hormones secreted from both central and peripheral tissues. Because of the complexity of growth regulation, the precise mechanism of control remains unknown and likely involves novel factors that remain to be elucidated.

We recently identified a novel cDNA that encodes the precursor of a small hypothalamic secretory protein in chickens, mice, and rats (Ukena et al., 2014, Matsuura et al., 2017, Iwakoshi-Ukena et al., 2017). The precursor protein is cleaved between a signal peptide sequence and a dibasic amino acids cleavage site to produce the mature protein, which is then modified with C-terminus amidation. Because the C-terminal amino acids of the small protein are Gly-Leu-NH2, the small protein was named neurosecretory protein GL (NPGL) (Ukena et al., 2014). Morphological analysis indicated that NPGL was produced in the medial mammillary nucleus (MM) and the infundibular nucleus (IN) within the hypothalamic infundibulum of the chicken (Ukena et al., 2014, Shikano et al., 2018). NPGL mRNA levels increase during post-hatching development (Ukena et al., 2014). Chronic subcutaneous infusion of NPGL for four days promotes body growth gain without affecting food intake in chicks (Ukena et al., 2014). Additionally, intracerebroventricular infusion of NPGL increases food intake and body mass gain (Shikano et al., 2018). These findings suggest that NPGL participates in growth and feeding regulation in chicks. More recently, we also found that NPGL stimulates feeding behavior in rodents (Matsuura et al., 2017, Iwakoshi-Ukena et al., 2017). Thus, NPGL plays important roles in the regulation of growth and energy homeostasis in birds and rodents.

Furthermore, genome database search indicates that the NPGL gene has a paralogous gene named neurosecretory protein GM (NPGM) and that NPGM and NPGL are highly conserved in vertebrates, including chicken, rat, and human (Ukena et al., 2014). Homology between NPGM and NPGL is 54% in chicken (Table 1). Therefore, we expected that NPGM might also have some significant biological actions in vertebrates. In the present study, to elucidate biological actions of NPGM, we investigated the effect of chronic subcutaneous infusion of NPGM in chicks.

Section snippets

Animals

Male layer chicks (Gallus domesticus, one-day-old) were purchased from a commercial hatchery (Nihon Layer, Gifu, Japan) and habituated in a windowless room that was maintained at 28 °C and on a consistent light/dark cycle: 20 h light (4:00–24:00) and 4 h dark (0:00–4:00). The chicks were provided food and water ad libitum. Chicks were bred in group breeding or separated into individual breeding cages from 4 days old to measure individual food and water intake. The experimental protocols were in

Effect of subcutaneous infusion of NPGM on body mass gain, food intake, water intake, and body composition

To investigate the biological action of NPGM, we performed chronic subcutaneous infusion of NPGM for six days in chicks under the group breeding condition. Infusion of the high dose (24 nmol/day) of NPGM significantly increased body mass gain as measured at days 5 and 6 (Fig. 1). The group that received an infusion of the low dose (2.4 nmol/day) of NPGM showed an intermediate body mass gain between the groups receiving the vehicle and the high dose of NPGM (Fig. 1). Therefore, NPGM promoted

Discussion

Our previous studies showed that NPGL regulated growth and/or energy metabolism in chickens, mice, and rats (Ukena et al., 2014, Shikano et al., 2018, Matsuura et al., 2017, Iwakoshi-Ukena et al., 2017). Peripheral administration of NPGL increased body mass gain without increasing feeding behavior, and central administration induced body growth and appetite in chicks (Ukena et al., 2014, Shikano et al., 2018). The NPGL gene has a paralogous gene named NPGM, and these two paralogous genes appear

Disclosure statement

The authors have nothing to disclose.

Acknowledgments

We thank Mr. Kunihiro Kondo and Ms. Yuki Bessho for experimental support. This work was supported by the Japan Society for the Promotion of Science KAKENHI Grants (JP22687004, JP26291066, and JP15KK0259 to K.U., and JP25440171 and JP16K07440 to E.I.-U.), Grant-in-Aid for JSPS Fellows (15J03781 to K.S.), the Toray Science Foundation (K.U.), the Kieikai Research Foundation (K.U.), and the Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (K.U.).

Author contributions

K.U. conceived and designed the experiments. All authors performed the experiments and analyzed the data. K.S. and K.U. wrote the paper.

Cited by (7)

  • Pituitary gland

    2022, Sturkie's Avian Physiology
  • Overviews of avian neuropeptides and peptides

    2022, Sturkie's Avian Physiology
  • Subcutaneous infusion of neurosecretory protein GL promotes fat accumulation in mice

    2021, Heliyon
    Citation Excerpt :

    For control animals, a vehicle solution was used. The dose of NPGL was determined based on our previous study that subcutaneous administration of 24 nmol/day NPGM was effective on body mass gain, while that of low dose (2.4 nmol/day) did not show any effects in chicks [22]. Prior to subcutaneous pump implantation onto the back of mice, pumps were filled with vehicle or NPGL solution and soaked in 0.9% NaCl at 37 °C overnight.

  • Neurosecretory protein GL/neurosecretory protein GM

    2021, Handbook of Hormones: Comparative Endocrinology for Basic and Clinical Research
View all citing articles on Scopus
View full text